Novo Holdings A/S bought MGX
February 13, 2024 · Form 4 insider transaction
Novo Holdings A/S bought 800,000 shares of Metagenomi Therapeutics, Inc. at $15.00 per share, a transaction worth $12.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
800,000
Price
$15.00
Total value
$12.00M
InsiderNovo Holdings A/S
Role10% owner
SecurityCOMMON STOCK
Transaction codeP: Open-market purchase
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after1,739,175
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a purchase from the underwriters in the Issuer's initial public offering.